Elisabetta Meacci received her B.S. degree in biological sciences in 1987 from the University of Florence, Florence, Italy, in 1987; she completed the postgraduate studies in pharmacology at the same university and received the Ph.D. degree in biochemistry in 1996. She was a Fogarty/NIH Visiting Fellow at the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, USA, working in the laboratory coordinated by Dr. Vincent Manganiello. During this period, she participated to molecular biology studies aimed to characterize cAMP-specific phosphodiesterase. In 1996, she won a National Research Council Fellowship and spent a second period abroad (1996–1998) as Fogarty/NIH Visiting Associate in the laboratory coordinated by Dr. Joel Moss, Chief of Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, USA. During this period, her research was focused on cytohesin-1, a guanine nucleotide exchange factor specific for monomeric GTP-binding proteins of ARF family. In 1998, she got a position as a Researcher (Biochemistry, BIO/10) at the Faculty of Sciences, University of Florence, Florence, Italy. In May 2002, she was positively evaluated as an Associate Professor (Molecular Biology, BIO/11), and she got a position as an Associate Professor (Molecular Biology, BIO/11) at the same faculty. Currently, she is the President of the master course in molecular biotechnologies. In the last 15 years, her research has been focused on the sphingolipid metabolism, the signalling pathways triggered by sphingosine 1-phosphate in various mammalian cell types (muscle and cardiac cells and tumoral cells), and on the regulation of enzymes involved in the control of cellular levels of lipid mediators, such as phospholipase D, sphingomyelinase, and ceramidase. She is a coauthor of 64 publications in international journals.
Biography Updated on 23 October 2012